从7岁至53岁哮喘与过敏的轨迹及其与肺功能和肺外共病特征的关联:一项前瞻性队列研究
该前瞻性队列研究基于塔斯马尼亚纵向健康研究,纳入3609名7-53岁参与者,采用潜在类别分析识别出五种哮喘与过敏轨迹及四种肺外共病特征。不同轨迹与不同肺外共病特征及COPD风险相关,可指导以可治疗特征为重点的个性化管理。
要点
- 其他哮喘与过敏轨迹仅与心理健康障碍特征相关。
核心结论
- 从童年至53岁不同的哮喘与过敏轨迹与不同的肺外共病特征及 varying 的COPD风险相关。
- 这些发现可指导临床指南和管理中聚焦可治疗特征的个性化方法。
- 共病特征是早期识别和干预的新靶点。
研究设计与样本
- 前瞻性队列研究,数据来自塔斯马尼亚纵向健康研究,参与者7-53岁,最初在澳大利亚塔斯马尼亚招募。
- 最近一次随访(平均年龄53岁)邀请数据库中所有有联系方式的存活个体,无排除标准。
- 采用潜在类别分析识别7-53岁哮喘与过敏条件的纵向轨迹及53岁时自报肺外疾病特征。
- 使用回归模型分析哮喘与过敏轨迹与53岁时疾病特征及肺功能的关联。
主要发现
- 其他哮喘与过敏轨迹仅与以心理健康障碍为主的特征相关。
临床怎么用
- 临床中应识别哮喘与过敏的纵向轨迹,以评估COPD和肺外共病风险。
- 针对早发型持续型哮喘与过敏轨迹患者,应加强COPD监测和预防。
- 晚发型哮喘与过敏轨迹患者需关注多病共存,尤其是心血管疾病和心理健康问题。
- 管理策略可聚焦可治疗特征,实现个性化干预。
- 共病特征应作为早期识别和干预的靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Longitudinal trajectories of asthma and allergies from childhood to adulthood might be differentially associated with lung function and chronic obstructive pulmonary disease (COPD), but associations with extrapulmonary comorbidities have not been well investigated. We aimed to assess these trajectories and examine their associations with lung function outcomes and profiles of comorbidities. METHODS: In this prospective cohort study, data for asthma and related allergic conditions (ie, eczema, hay fever, and food allergy) were prospectively collected from the Tasmanian Longitudinal Health Study for participants aged 7-53 years originally recruited in Tasmania, Australia. All surviving individuals in the database with contact details were invited in the most recent follow-up (mean age 53 years). There were no exclusion criteria. With use of latent class analysis, we identified longitudinal trajectories of asthma and allergic conditions from 7-53 years, and profiles of self-reported extrapulmonary conditions recorded at 53 years. The associations between asthma and allergy trajectories and morbidity profiles and lung function at 53 years were investigated with regression models. FINDINGS: Between Sept 3, 2012, and Nov 8, 2016, of 6128 individuals invited, 3609 (58·9%) individuals were enrolled. We identified five asthma and allergy trajectories: minimal and least asthma and allergies (n= 1767 [49·0%]); late-onset hay fever, no asthma (n=1065 [29·5%]); early-onset remitted asthma and allergies (n=236 [6·5%]); late-onset asthma and allergies (n=317 [8·8%]); and early-onset persistent asthma and allergies (n=224 [6·2%]); and four profiles of extrapulmonary morbidities: minimal or least disease (n=2206 [61·1%]); dominant mental health disorders (n=861 [23·9%]); dominant cardiovascular diseases or risks (n=424 [11·7%]); and multiple disorders (n=117 [3·2%]). The late-onset asthma and allergies trajectory was predominantly associated with the multiple disorders profile (relative risk ratio 3·3 [95% CI 1·9-5·9]), whereas the other asthma and allergy trajectories were associated only with the dominant mental health disorders profile. Both spirometrically defined and clinical COPD were most strongly associated with the early-onset persistent asthma and allergies trajectory (odds ratio [OR] 5·3 [95% CI 3·2-8·6]) and also with the late-onset asthma and allergies trajectory (OR 3·8 [2·4-6·1]). INTERPRETATION: Distinct longitudinal trajectories of asthma and allergic disease from childhood to 53 years are associated with different profiles of extrapulmonary comorbidities and varying risk of COPD. These findings can inform a personalised approach in clinical guidelines and management focusing on treatable traits. Comorbidity profiles are a new target for early identification and intervention. FUNDING: National Health and Medical Research Council of Australia, EU's Horizon 2020, The University of Melbourne, Clifford Craig Medical Research Trust of Tasmania, The Victorian, Queensland & Tasmanian Asthma Foundations, The Royal Hobart Hospital, Helen MacPherson Smith Trust, and GlaxoSmithKline.
引用
- Bui DS, Lodge CJ, Perret JL, et al. Trajectories of asthma and allergies from 7 years to 53 years and associations with lung function and extrapulmonary comorbidity profiles: a prospective cohort study. Lancet Respir Med. 2020. PMID: 33217367. doi:10.1016/S2213-2600(20)30413-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。